304 related articles for article (PubMed ID: 19299146)
21. Synthesis and biological evaluation of novel flavone-8-acetic acid derivatives as reversible inhibitors of aminopeptidase N/CD13.
Bauvois B; Puiffe ML; Bongui JB; Paillat S; Monneret C; Dauzonne D
J Med Chem; 2003 Aug; 46(18):3900-13. PubMed ID: 12930151
[TBL] [Abstract][Full Text] [Related]
22. Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.
Tu G; Li S; Huang H; Li G; Xiong F; Mai X; Zhu H; Kuang B; Xu WF
Bioorg Med Chem; 2008 Jul; 16(14):6663-8. PubMed ID: 18571419
[TBL] [Abstract][Full Text] [Related]
23. Novel leucine ureido derivatives as inhibitors of aminopeptidase N (APN).
Ma C; Jin K; Cao J; Zhang L; Li X; Xu W
Bioorg Med Chem; 2013 Apr; 21(7):1621-7. PubMed ID: 23453219
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and preliminary activity evaluation of novel peptidomimetics as aminopeptidase N/CD13 inhibitors.
Li X; Wang J; Zhang L; Xu W
Arch Pharm (Weinheim); 2011 Aug; 344(8):494-504. PubMed ID: 21681811
[TBL] [Abstract][Full Text] [Related]
25. Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.
Cui SX; Qu XJ; Gao ZH; Zhang YS; Zhang XF; Zhao CR; Xu WF; Li QB; Han JX
Cancer Lett; 2010 Jun; 292(2):153-62. PubMed ID: 20042271
[TBL] [Abstract][Full Text] [Related]
26. Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).
Li X; Wang Y; Wu J; Li Y; Wang Q; Xu W
Bioorg Med Chem; 2009 Apr; 17(8):3061-71. PubMed ID: 19339187
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.
Mou J; Fang H; Liu Y; Shang L; Wang Q; Zhang L; Xu W
Bioorg Med Chem; 2010 Jan; 18(2):887-95. PubMed ID: 19969464
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor.
Luan Y; Wang Q; Liu N; Mou J; Jiao X; Fang H; Li M; Xu W
Anticancer Drugs; 2011 Jan; 22(1):99-103. PubMed ID: 21048494
[TBL] [Abstract][Full Text] [Related]
29. New aromatic monoesters of alpha-aminoaralkylphosphonic acids as inhibitors of aminopeptidase N/CD13.
Grzywa R; Sokol AM; Sieńczyk M; Radziszewicz M; Kościołek B; Carty MP; Oleksyszyn J
Bioorg Med Chem; 2010 Apr; 18(8):2930-6. PubMed ID: 20347318
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors.
Zhang X; Zhang L; Zhang J; Feng J; Yuan Y; Fang H; Xu W
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):545-51. PubMed ID: 22380779
[TBL] [Abstract][Full Text] [Related]
31. Novel β-dicarbonyl derivatives as inhibitors of aminopeptidase N (APN).
Ma C; Li X; Liang X; Jin K; Cao J; Xu W
Bioorg Med Chem Lett; 2013 Sep; 23(17):4948-52. PubMed ID: 23860593
[TBL] [Abstract][Full Text] [Related]
32. Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.
Li Q; Fang H; Xu W
Bioorg Med Chem Lett; 2007 May; 17(10):2935-8. PubMed ID: 17433673
[TBL] [Abstract][Full Text] [Related]
33. Amino-benzosuberone: a novel warhead for selective inhibition of human aminopeptidase-N/CD13.
Albrecht S; Al-Lakkis-Wehbe M; Orsini A; Defoin A; Pale P; Salomon E; Tarnus C; Weibel JM
Bioorg Med Chem; 2011 Feb; 19(4):1434-49. PubMed ID: 21292493
[TBL] [Abstract][Full Text] [Related]
34. Novel hydroxamic acid-related phosphinates: inhibition of neutral aminopeptidase N (APN).
Drag M; Grzywa R; Oleksyszyn J
Bioorg Med Chem Lett; 2007 Mar; 17(6):1516-9. PubMed ID: 17270439
[TBL] [Abstract][Full Text] [Related]
35. First synthesis of alpha-aminoalkyl-(N-substituted)thiocarbamoyl-phosphinates: inhibitors of aminopeptidase N (APN/CD13) with the new zinc-binding group.
Grzywa R; Oleksyszyn J
Bioorg Med Chem Lett; 2008 Jul; 18(13):3734-6. PubMed ID: 18524593
[TBL] [Abstract][Full Text] [Related]
36. Identification of very potent inhibitor of human aminopeptidase N (CD13).
Grzywa R; Oleksyszyn J; Salvesen GS; Drag M
Bioorg Med Chem Lett; 2010 Apr; 20(8):2497-9. PubMed ID: 20307982
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and preliminary evaluation of α-sulfonyl γ-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.
Zhang J; Li X; Jiang Y; Feng J; Li X; Zhang Y; Xu W
Bioorg Med Chem; 2014 Jun; 22(11):3055-64. PubMed ID: 24755524
[TBL] [Abstract][Full Text] [Related]
38. Discovery of a synthetic Aminopeptidase N inhibitor LB-4b as a potential anticancer agent.
Su L; Jia Y; Wang X; Zhang L; Fang H; Xu W
Bioorg Med Chem Lett; 2013 May; 23(9):2512-7. PubMed ID: 23528299
[TBL] [Abstract][Full Text] [Related]
39. Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses.
Reinhold D; Biton A; Goihl A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S
Ann N Y Acad Sci; 2007 Sep; 1110():402-9. PubMed ID: 17911455
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of tripeptide boronic acid proteasome inhibitors.
Zhu Y; Yao S; Xu B; Ge Z; Cui J; Cheng T; Li R
Bioorg Med Chem; 2009 Oct; 17(19):6851-61. PubMed ID: 19747832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
